Acknowledgement
Supported by : Korea Health Industry Development Institute (KHIDI), National Research Foundation of Korea (NRF)
References
- Sasaki, H. et al. PDE5 inhibitor efficacy is estrogen dependent in female heart disease. J. Clin. Invest. 124, 2464-2471 (2014). https://doi.org/10.1172/JCI70731
- Bittner, V. Menopause, age, and cardiovascular risk: a complex relationship. J. Am. Coll. Cardiol. 54, 2374-2375 (2009). https://doi.org/10.1016/j.jacc.2009.10.008
- Coylewright, M., Reckelhoff, J. F. & Ouyang, P. Menopause and hypertension: an age-old debate. Hypertension 51, 952-959 (2008). https://doi.org/10.1161/HYPERTENSIONAHA.107.105742
- Kim, E. S. & Menon, V. Status of women in cardiovascular clinical trials. Arterioscler. Thromb. Vasc. Biol. 29, 279-283 (2009). https://doi.org/10.1161/ATVBAHA.108.179796
- Reckelhoff, J. F. & Maric, C. Sex and gender differences in cardiovascular-renal physiology and pathophysiology. Steroids 75, 745-746 (2010). https://doi.org/10.1016/j.steroids.2010.05.020
- Grodstein, F. et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133, 933-941 (2000). https://doi.org/10.7326/0003-4819-133-12-200012190-00008
- Rosano, G. M., Vitale, C. & Fini, M. Cardiovascular aspects of menopausal hormone replacement therapy. Climacteric 12(Suppl 1), 41-46 (2009). https://doi.org/10.1080/13697130903012306
- Manson, J. E. et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349, 523-534 (2003). https://doi.org/10.1056/NEJMoa030808
- Hulley, S. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613 (1998). https://doi.org/10.1001/jama.280.7.605
- Hulley, S. et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288, 58-66 (2002). https://doi.org/10.1001/jama.288.1.58
- Hodis, H. N. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart. Cleve. Clin. J. Med. 75(Suppl 4), S3-S12 (2008).
- Schnatz, P. F. Hormonal therapy: does it increase or decrease cardiovascular risk? Obstet. Gynecol. Surv. 61, 673-681 (2006). https://doi.org/10.1097/01.ogx.0000238674.98471.bb
- Haines, C. J. & Farrell, E. Menopause management: a cardiovascular risk-based approach. Climacteric 13, 328-339 (2010). https://doi.org/10.3109/13697130903450154
- Harman, S. M. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend. Med. 3, 254-269 (2006). https://doi.org/10.1016/S1550-8579(06)80214-7
- Watts, S. W. 5-HT in systemic hypertension: foe, friend or fantasy? Clin. Sci. 108, 399-412 (2005). https://doi.org/10.1042/CS20040364
- Watts, S. W., Morrison, S. F., Davis, R. P. & Barman, S. M. Serotonin and blood pressure regulation. Pharmacol. Rev. 64, 359-388 (2012). https://doi.org/10.1124/pr.111.004697
- Brenner, B. et al. Plasma serotonin levels and the platelet serotonin transporter. J. Neurochem. 102, 206-215 (2007). https://doi.org/10.1111/j.1471-4159.2007.04542.x
- Haliloglu, B. et al. Serotonin dilemma in postmenopausal women: is it low or high? Maturitas 60, 148-152 (2008). https://doi.org/10.1016/j.maturitas.2008.04.013
- Sung, D. J. et al. Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase. Exp. Mol. Med. 45, e67 (2013). https://doi.org/10.1038/emm.2013.116
- Lin, H. et al. Enhancement of 5-HT2A receptor function and blockade of Kv1.5 by MK801 and ketamine: implications for PCP derivative-induced disease models. Exp. Mol. Med. 50, 47 (2018). https://doi.org/10.1038/s12276-018-0073-6
- Lu, R. et al. c-Src tyrosine kinase, a critical component for 5-HT2A receptormediated contraction in rat aorta. J. Physiol. 586, 3855-3869 (2008). https://doi.org/10.1113/jphysiol.2008.153593
- Bae, Y. M. et al. Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+currents. Biochem. Biophys. Res. Commun. 347, 468-476 (2006). https://doi.org/10.1016/j.bbrc.2006.06.116
- Cogolludo, A. et al. Serotonin inhibits voltage-gated K+currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization. Circ. Res. 98, 931-938 (2006). https://doi.org/10.1161/01.RES.0000216858.04599.e1
- Doggrell, S. A. The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation. Expert. Opin. Investig. Drugs 12, 805-823 (2003). https://doi.org/10.1517/13543784.12.5.805
- Cummings, S. A., Groszmann, R. J. & Kaumann, A. J. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br. J. Pharmacol. 89, 501-513 (1986). https://doi.org/10.1111/j.1476-5381.1986.tb11150.x
- Thompson, L. P. & Webb, R. C. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension 9, 277-281 (1987). https://doi.org/10.1161/01.HYP.9.3.277
- Huzoor, A., Chen, N. Y., Fossen, D. V. & Wallace, D. Increased vascular contractile sensitivity to serotonin in spontaneously hypertensive rats is linked with increased turnover of phosphoinositide. Life. Sci. 45, 577-583 (1989). https://doi.org/10.1016/0024-3205(89)90042-8
- Dohi, Y. & Luscher, T. F. Endothelin in hypertensive resistance arteries. Intraluminal Extra. Dysfunct. Hypertens. 18, 543-549 (1991). https://doi.org/10.1161/01.HYP.18.4.543
- Webb, R. C., Schreur, K. D. & Papadopoulos, S. M. Oscillatory contractions in vertebral arteries from hypertensive subjects. Clin. Physiol. 12, 69-77 (1992). https://doi.org/10.1111/j.1475-097X.1992.tb00294.x
- Moreno, L., Martinez-Cuesta, M. A., Pique, J. M., Bosch, J. & Esplugues, J. V. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn Schmiede. Arch. Pharmacol. 354, 474-480 (1996). https://doi.org/10.1007/BF00168439
- Holm, A. & Nilsson, B. O. Identification and characterization of new mechanisms in vascular oestrogen signalling. Basic. Clin. Pharmacol. Toxicol. 113, 287-293 (2013).
- Watanabe, T. et al. Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation. Cardiovasc. Res. 59, 734-744 (2003). https://doi.org/10.1016/S0008-6363(03)00496-6
- Menazza, S. & Murphy, E. The expanding complexity of estrogen receptor signaling in the cardiovascular system. Circ. Res. 118, 994-1007 (2016). https://doi.org/10.1161/CIRCRESAHA.115.305376
- Sudhir, K. et al. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26, 807-814 (1995). https://doi.org/10.1016/0735-1097(95)00248-3
- Teoh, H., Quan, A., Leung, S. W. & Man, R. Y. Differential effects of 17betaestradiol and testosterone on the contractile responses of porcine coronary arteries. Br. J. Pharmacol. 129, 1301-1308 (2000). https://doi.org/10.1038/sj.bjp.0703164
- Karas, R. H. et al. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ. Res. 89, 534-539 (2001). https://doi.org/10.1161/hh1801.097239
- Mendelsohn, M. E. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ. Res. 87, 956-960 (2000). https://doi.org/10.1161/01.RES.87.11.956
- Chen, Z. et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406 (1999). https://doi.org/10.1172/JCI5347
- Haynes, M. P. et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677-682 (2000). https://doi.org/10.1161/01.RES.87.8.677
- Simoncini, T. et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541 (2000). https://doi.org/10.1038/35035131
- Gustafsson, J. A. Estrogen receptor beta--getting in on the action? Nat. Med. 3, 493-494 (1997). https://doi.org/10.1038/nm0597-493
- Katzenellenbogen, B. S. & Korach, K. S. A new actor in the estrogen receptor drama--enter ER-beta. Endocrinology 138, 861-862 (1997). https://doi.org/10.1210/endo.138.3.5080
- Gustafsson, J. A. Estrogen receptor beta--a new dimension in estrogen mechanism of action. J. Endocrinol. 163, 379-383 (1999). https://doi.org/10.1677/joe.0.1630379
- Iafrati, M. D. et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3, 545-548 (1997). https://doi.org/10.1038/nm0597-545
- Karas, R. H., Patterson, B. L. & Mendelsohn, M. E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89, 1943-1950 (1994). https://doi.org/10.1161/01.CIR.89.5.1943
- Kim-Schulze, S. et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94, 1402-1407 (1996). https://doi.org/10.1161/01.CIR.94.6.1402
- Lindner, V. et al. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ. Res. 83, 224-229 (1998). https://doi.org/10.1161/01.RES.83.2.224
- Venkov, C. D., Rankin, A. B. & Vaughan, D. E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94, 727-733 (1996). https://doi.org/10.1161/01.CIR.94.4.727
- Losordo, D. W., Kearney, M., Kim, E. A., Jekanowski, J. & Isner, J. M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89, 1501-1510 (1994). https://doi.org/10.1161/01.CIR.89.4.1501
- Register, T. C. & Adams, M. R. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J. Steroid Biochem. Mol. Biol. 64, 187-191 (1998). https://doi.org/10.1016/S0960-0760(97)00155-6
- Berdanier, C. D., Dwyer, J. T. & Feldman, E. B. Plant foods and phytochemicals in human health. Handbook of Nutrition and Food. (CRC Press, Boca Raton, FL, 2007).
Cited by
- Comparison of Vascular Responses to Vasoconstrictors in Human Placenta in Preeclampsia between Preterm and Later Term vol.21, pp.8, 2020, https://doi.org/10.2174/1389201021666191217114111